85 related articles for article (PubMed ID: 3712094)
1. Immunoreactivity assay for labeled anti-melanoma monoclonal antibodies.
Beaumier PL; Neuzil D; Yang HM; Noll EA; Kishore R; Eary JF; Krohn KA; Nelp WB; Hellström KE; Hellström I
J Nucl Med; 1986 Jun; 27(6):824-8. PubMed ID: 3712094
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antiidiotypic antibodies related to the p97 human melanoma antigen.
Kahn M; Hellström I; Estin CD; Hellström KE
Cancer Res; 1989 Jun; 49(12):3157-62. PubMed ID: 2470502
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal anti-idiotypic antibodies to human melanoma-associated proteoglycan antigen: generation and characterization of anti-idiotype antibodies.
Chattopadhyay P; Sneed D; Rosenberg J; Starkey J; Robertson N; Leonard J; Raychaudhuri S
Cancer Res; 1991 Jun; 51(12):3183-92. PubMed ID: 1710168
[TBL] [Abstract][Full Text] [Related]
4. Characterization of monoclonal antibody 155.8 and partial characterization of its proteoglycan antigen on human melanoma cells.
Harper JR; Bumol TF; Reisfeld RA
J Immunol; 1984 Apr; 132(4):2096-104. PubMed ID: 6199423
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies to human melanoma-associated antigens: an amplified enzyme-linked immunosorbent assay for the detection of antigen, antibody, and immune complexes.
Morgan AC; McIntyre RF
Cancer Res; 1983 Jul; 43(7):3155-9. PubMed ID: 6850625
[TBL] [Abstract][Full Text] [Related]
6. Immunocytochemical study on internalization of anti-carbohydrate monoclonal antibodies.
Kusano A; Ohta S; Shitara K; Hanai N
Anticancer Res; 1993; 13(6A):2207-12. PubMed ID: 8297135
[TBL] [Abstract][Full Text] [Related]
7. Effects of temperature on radiochemical purity and immunoreactivity of radiolabeled monoclonal antibody 1H10.
Huang WS; Cherng SC; Jen TK; Yu MH; Yeh MY
J Nucl Med Technol; 2000 Sep; 28(3):182-5. PubMed ID: 11001503
[TBL] [Abstract][Full Text] [Related]
8. Melanoma antibodies: specificity and interaction with melanoma and cytotoxic T-cells.
Dippold WG; Knuth A; Meyer zum Büschenfelde KH
Behring Inst Mitt; 1984 May; (74):14-8. PubMed ID: 6332614
[TBL] [Abstract][Full Text] [Related]
9. Immunoassay for melanoma-associated proteoglycan in the sera of patients using monoclonal and polyclonal antibodies.
Ross AH; Herlyn M; Ernst CS; Guerry D; Bennicelli J; Ghrist BF; Atkinson B; Koprowski H
Cancer Res; 1984 Oct; 44(10):4642-7. PubMed ID: 6380710
[TBL] [Abstract][Full Text] [Related]
10. Structural characterization of human melanoma-associated antigen p97 with monoclonal antibodies.
Brown JP; Nishiyama K; Hellström I; Hellström KE
J Immunol; 1981 Aug; 127(2):539-46. PubMed ID: 6166674
[TBL] [Abstract][Full Text] [Related]
11. Characterization of human anti-high molecular weight-melanoma-associated antigen single-chain Fv fragments isolated from a phage display antibody library.
Desai SA; Wang X; Noronha EJ; Kageshita T; Ferrone S
Cancer Res; 1998 Jun; 58(11):2417-25. PubMed ID: 9622083
[TBL] [Abstract][Full Text] [Related]
12. Cancer vaccines: an update with special focus on ganglioside antigens.
Bitton RJ; Guthmann MD; Gabri MR; Carnero AJ; Alonso DF; Fainboim L; Gomez DE
Oncol Rep; 2002; 9(2):267-76. PubMed ID: 11836591
[TBL] [Abstract][Full Text] [Related]
13. Fluctuations in the expression of a glycolipid antigen associated with differentiation of melanoma cells monitored by a monoclonal antibody, Leo Mel 3.
Werkmeister JA; Triglia T; Mackay IR; Dowling JP; Varigos GA; Morstyn G; Burns GF
Cancer Res; 1987 Jan; 47(1):225-30. PubMed ID: 3791209
[TBL] [Abstract][Full Text] [Related]
14. High-level iodination of monoclonal antibody fragments for radiotherapy.
Ferens JM; Krohn KA; Beaumier PL; Brown JP; Hellström I; Hellström KE; Carrasquillo JA; Larson SM
J Nucl Med; 1984 Mar; 25(3):367-70. PubMed ID: 6699726
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibodies to human melanoma associated antigens: study of their specificity and visualization at the cellular level of the antigenic distribution.
Libert A; Ghanem G; Arnould R; Vercammen-Grandjean A; Carrel S; Lejeune F
Anticancer Res; 1983; 3(4):219-25. PubMed ID: 6576727
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibody-defined correlations in melanoma between levels of GD2 and GD3 antigens and antibody-mediated cytotoxicity.
Thurin J; Thurin M; Kimoto Y; Herlyn M; Lubeck MD; Elder DE; Smereczynska M; Karlsson KA; Clark WM; Steplewski Z
Cancer Res; 1987 Mar; 47(5):1229-33. PubMed ID: 3815333
[TBL] [Abstract][Full Text] [Related]
17. Sequential immunization of melanoma patients with GD3 ganglioside vaccine and anti-idiotypic monoclonal antibody that mimics GD3 ganglioside.
Chapman PB; Wu D; Ragupathi G; Lu S; Williams L; Hwu WJ; Johnson D; Livingston PO
Clin Cancer Res; 2004 Jul; 10(14):4717-23. PubMed ID: 15269144
[TBL] [Abstract][Full Text] [Related]
18. The expression of tumor-associated antigens in primary and metastatic human malignant melanoma.
Brüggen J; Bröcker EB; Suter L; Redmann K; Sorg C
Behring Inst Mitt; 1984 May; (74):19-23. PubMed ID: 6477352
[TBL] [Abstract][Full Text] [Related]
19. Specific killing of human melanoma cells by 125I-labeled 9.2.27 monoclonal antibody.
Lindmo T; Boven E; Mitchell JB; Morstyn G; Bunn PA
Cancer Res; 1985 Oct; 45(10):5080-7. PubMed ID: 4027987
[TBL] [Abstract][Full Text] [Related]
20. Common human melanoma-associated antigen(s) detected by monoclonal antibodies.
Carrel S; Accolla RS; Carmagnola AL; Mach JP
Cancer Res; 1980 Jul; 40(7):2523-8. PubMed ID: 6155995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
